Literature DB >> 22427347

Competing risk analyses: how are they different and why should you care?

Rick Chappell1.   

Abstract

Competing risks are events in which at least one precludes the observation of the other, such as toxicity and death. This commentary discusses and distinguishes between the two common types of competing risk analyses, the Kaplan-Meier and cumulative incidence curves. ©2012 AACR.

Entities:  

Mesh：

Year:  2012        PMID： 22427347     DOI： 10.1158/1078-0432.CCR-12-0455

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  19 in total

1.  Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.

Authors:  Kyuichi Kadota; Yi-Chen Yeh; Jonathan Villena-Vargas; Leonid Cherkassky; Esther N Drill; Camelia S Sima; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

2.  Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Hideki Ujiie; Daniel H Buitrago; Kaitlin M Woo; Camelia S Sima; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Camelia S Sima; Hideki Ujiie; Nabil P Rizk; David R Jones; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

4.  Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis.

Authors:  Erin L Abner; Peter T Nelson; Gregory A Jicha; Gregory E Cooper; David W Fardo; Frederick A Schmitt; Richard J Kryscio
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer.

Authors:  Ming-Ching Lee; Daniel H Buitrago; Kyuichi Kadota; Hideki Ujiie; Kaitlin Woo; Camelia S Sima; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

6.  Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Inderpal S Sarkaria; Camelia S Sima; Xiaoyu Jia; Akihiko Yoshizawa; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Cancer       Date:  2012-10-23       Impact factor: 6.860

7.  Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma.

Authors:  Shaohua Lu; Kay See Tan; Kyuichi Kadota; Takashi Eguchi; Sarina Bains; Natasha Rekhtman; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2016-09-28       Impact factor: 15.609

8.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.

Authors:  R Taylor Ripley; Robert R McMillan; Camelia S Sima; Saad M Hasan; Usman Ahmad; Feiran Lou; David R Jones; Valerie W Rusch; Nabil P Rizk; James Huang
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

9.  Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.

Authors:  Ane L Appelt; Ivan R Vogelius; John Pløen; Søren R Rafaelsen; Jan Lindebjerg; Birgitte M Havelund; Søren M Bentzen; Anders Jakobsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

10.  Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.

Authors:  Kyuichi Kadota; Jonathan Villena-Vargas; Akihiko Yoshizawa; Noriko Motoi; Camelia S Sima; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.